Masood A - Search Results

1

Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.

Pasvolsky O, Milton DR, Masood A, Sami SS, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Saeed A, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: masood a. Am J Hematol. 2023 Oct;98(10):1571-1578. doi: 10.1002/ajh.27029. Epub 2023 Jul 17. Am J Hematol. 2023. PMID: 37461327

2

Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.

Pasvolsky O, Milton DR, Rauf M, Tanner MR, Bashir Q, Srour S, Tang G, Saini N, Ramdial J, Masood A, Nieto Y, Lee HC, Patel KK, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Pasvolsky O, et al. Among authors: masood a. Transplant Cell Ther. 2022 Nov;28(11):752.e1-752.e6. doi: 10.1016/j.jtct.2022.07.028. Epub 2022 Aug 5. Transplant Cell Ther. 2022. PMID: 35940528 Free article.

3

[No title available]

[No authors listed] [No authors listed] PMID: 36164172

4

Treatment of Light Chain Deposition Disease: A Systematic Review.

Masood A, Ehsan H, Iqbal Q, Salman A, Hashmi H. Masood A, et al. J Hematol. 2022 Aug;11(4):123-130. doi: 10.14740/jh1038. Epub 2022 Aug 30. J Hematol. 2022. PMID: 36118549 Free PMC article. Review.

5

Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature.

Masood A, Iqbal Q, Ehsan H, Davis JA, Hansen DK, Hashmi H. Masood A, et al. Ann Hematol. 2022 Dec;101(12):2601-2610. doi: 10.1007/s00277-022-04999-1. Epub 2022 Oct 10. Ann Hematol. 2022. PMID: 36214853 Review.

6

Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma.

Ehsan H, Wahab A, Shah Z, Sana MK, Masood A, Rafae A, Hashmi H. Ehsan H, et al. Among authors: masood a. J Hematol. 2021 Jun;10(3):89-97. doi: 10.14740/jh844. Epub 2021 Jun 16. J Hematol. 2021. PMID: 34267845 Free PMC article. Review.

7

Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature.

Asghar N, Masood A, Dhaliwal A, Khurana S, Davis J, Hashmi H, Husnain M. Asghar N, et al. Among authors: masood a. Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):15-21. doi: 10.1016/j.clml.2022.09.008. Epub 2022 Oct 7. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36328891 Review.

8

Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature.

Masood A, Wahab A, Iqbal Q, Davis J, Ehsan H, Hashmi H. Masood A, et al. Bone Marrow Transplant. 2022 Jun;57(6):866-873. doi: 10.1038/s41409-022-01668-9. Epub 2022 Apr 11. Bone Marrow Transplant. 2022. PMID: 35411107 Review.

9

Durable remission of acute myeloid leukemia in an elderly patient following a limited course of azacitidine and venetoclax.

Ehsan H, Iqbal Q, Masood A, Grunwald MR. Ehsan H, et al. Among authors: masood a. Leuk Res Rep. 2022 Aug 17;18:100345. doi: 10.1016/j.lrr.2022.100345. eCollection 2022. Leuk Res Rep. 2022. PMID: 36051639 Free PMC article.

10

Investigating a hybrid extreme learning machine coupled with Dingo Optimization Algorithm for modeling liquefaction triggering in sand-silt mixtures.

Hameed MM, Masood A, Srivastava A, Abd Rahman N, Mohd Razali SF, Salem A, Elbeltagi A. Hameed MM, et al. Among authors: masood a. Sci Rep. 2024 May 11;14(1):10799. doi: 10.1038/s41598-024-61059-6. Sci Rep. 2024. PMID: 38734717 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page